These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18773265)
1. Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area. Dewi NA; Yuzawa M; Tochigi K; Kawamura A; Mori R Jpn J Ophthalmol; 2008; 52(4):277-281. PubMed ID: 18773265 [TBL] [Abstract][Full Text] [Related]
2. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004 [TBL] [Abstract][Full Text] [Related]
3. Sequence of early vascular events after photodynamic therapy. Michels S; Schmidt-Erfurth U Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655 [TBL] [Abstract][Full Text] [Related]
4. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia. Parodi MB; Da Pozzo S; Ravalico G Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389 [TBL] [Abstract][Full Text] [Related]
6. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498 [TBL] [Abstract][Full Text] [Related]
7. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy. Iriyama A; Obata R; Inoue Y; Takahashi H; Tamaki Y; Yanagi Y Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556 [TBL] [Abstract][Full Text] [Related]
8. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Schmidt-Erfurth UM; Michels S Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383 [TBL] [Abstract][Full Text] [Related]
9. Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration. Eter N; Vogel A; Inhetvin-Hutter C; Spitznas M Eur J Ophthalmol; 2003 Oct; 13(8):687-92. PubMed ID: 14620172 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Ladd BS; Solomon SD; Bressler NM; Bressler SB Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027 [TBL] [Abstract][Full Text] [Related]
11. Time course and morphology of vascular effects associated with photodynamic therapy. Schmidt-Erfurth U; Niemeyer M; Geitzenauer W; Michels S Ophthalmology; 2005 Dec; 112(12):2061-9. PubMed ID: 16325705 [TBL] [Abstract][Full Text] [Related]
12. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Cho M; Barbazetto IA; Freund KB Am J Ophthalmol; 2009 Jul; 148(1):70-8.e1. PubMed ID: 19403115 [TBL] [Abstract][Full Text] [Related]
13. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography. Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828 [TBL] [Abstract][Full Text] [Related]
14. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991 [TBL] [Abstract][Full Text] [Related]
16. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration. Obata R; Yanagi Y; Kami J; Takahashi H; Inoue Y; Tamaki Y Jpn J Ophthalmol; 2006; 50(4):354-360. PubMed ID: 16897221 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216 [TBL] [Abstract][Full Text] [Related]